- ►annals.org [PDF] DM Herrington - Annals of internal medicine, 1999 - Am Coll Physicians The Heart and Estrogen/progestin Replacement Study (HERS) found no overall effect of 4.1
years of therapy with estrogen plus progestin for secondary prevention of coro- nary heart disease
in postmenopausal women. However, within the overall null effect, a 50% increase in ... Cited by 109 - Related articles - BL Direct - All 8 versions
ДМ Херрингтон - mediasphera.ru Результаты испытания HERS (Heart and Estrogen/progestin Replacement Study)
показали, что применение в течение 4 лет комбинированной заместительной гормональной
терапии (ЗГТ) эстрогенами и прогестином для вторичной профилактики ... Related articles - All 2 versions
NR Effect - Ann Intern Med, 1999 - biblioteca.sp.san.gva.es The Heart and Estrogen/progestin Replacement Study (HERS) found no overall effect of 4.1
years of therapy with estrogen plus progestin for secondary prevention of coro- nary heart disease
in postmenopausal women. However, within the overall null effect, a 50% increase in ... Related articles - View as HTML
SRFLF Boehlen, YDP de Moerloose - titan.medhyg.ch L'hormonothérapie de substitution a démontré un bénéfice indiscutable dans le traitement des
symptômes climatériques de la ménopause et la prévention de l'ostéoporose. Jusqu'en
1996, il semblait que le risque de thrombose veineuse associé à la substitution ... Related articles - Cached
L Rosenberg, JR Palmer, LL Adams-Campbell - American Journal of Obstetrics …, 1997 - Elsevier On the basis of the 1995 questionnaire data, 422 postmenopausal women had had a “clot in
the leg or lungs” (cases) and 15,346 had not (controls). The age-adjusted odds ratio for female
hormone use (222 case and 7150 control users) was 1.4 (95% confidence interval 1.1 to ... Cited by 4 - Related articles - BL Direct - All 4 versions
[CITATION] Risks and benefits of estrogen plus progestin in healthy postmenopausal women. …
P Pietschmann, J Grisar, S Travica - JOURNAL FUR MINERALSTOFFWECHSEL, 2002 - kup.at P . b . b . GZ 0 2 Z 0 3 1 1 0 8 M , V erlagspostamt : 3 0 0 2 P urkersdorf , E rscheinungsort : 3
0 0 3 G ablitz ... P . b . b . GZ 0 2 Z 0 3 1 1 0 8 M , V erlagspostamt : 3 0 0 2 P urkersdorf , E rscheinungsort
: 3 0 0 3 G ablitz ... Österreichische Gesellschaft für Orthopädie und Orthopädische ... Related articles - View as HTML - BL Direct - All 4 versions
J Helmersson, P Mattsson, B Samar - Clinical Science, 2002 - cs.portlandpress.com The pathophysiology theory of migraine postulates a local, neurogenic inflammation and the
possible involvement of oxidative stress. We analysed the levels of 15-oxo-dihydro-prostaglandin
F 2a (a metabolite of prostaglandin F 2a ) and 8-iso-prostaglandin F 2a (a major ... Cited by 40 - Related articles - Cached - BL Direct - All 12 versions
G Wells, DM Herrington - Drugs &# 38; Aging, 1999 - ingentaconnect.com Abstract The Heart and Estrogen/Progestin Replacement Study (HERS) was the first
randomised, double-blind, placebo-controlled study to evaluate the outcome of hormone replacement
therapy (HRT) on subsequent cardiac events in postmeno- pausal women with ... Cited by 21 - Related articles - BL Direct - All 4 versions
RS Blumenthal, HA Zacur, SE Reis, WS Post - The American Journal of …, 2000 - Elsevier HERS was the first prospective randomized, double-blind, placebo-controlled trial of the effects
of HRT (with conjugated estrogen and medoxyprogesterone acetate) on CHD risk. It enrolled
2,763 postmenopausal women (average age 67 years). Surprisingly, after 4 years of ... Cited by 21 - Related articles - BL Direct - All 5 versions
